REgistry of MisOprostol 200 µg Vaginal dElivery System (REMOVE)

Trial Profile

REgistry of MisOprostol 200 µg Vaginal dElivery System (REMOVE)

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs Misoprostol (Primary)
  • Indications Labour induction
  • Focus Therapeutic Use
  • Acronyms REMOVE
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 15 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Aug 2015 Planned End Date changed from 1 Jul 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
    • 17 Aug 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top